A Randomized, Controlled, Double-Blind Study Comparing the Survival Benefit of Four Different Reverse Transcriptase Inhibitor Therapies (Three-Drug, Two-Drug, and Alternating Drug) for the Treatment of Advanced AIDSKeith Henry, James O. Kahn, Alejo Erice et al.|Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology|1998Cited by 86
Maternal Human Immunodeficiency Virus (HIV) Drug Resistance Is Associated With Vertical Transmission and Is Prevalent in Infected InfantsCeejay L. Boyce, Lisa M. Frenkel, Tatiana Sils et al.|Clinical Infectious Diseases|2021Cited by 23
Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202Cindy J. Bednasz, Mitchell Goldman, Ann C. Collier et al.|Antimicrobial Agents and Chemotherapy|2019Cited by 16